Mimood

A new study shows that patient-derived adult stem cells can be used to model major depressive disorder and test how a patient may respond to medication and that fish oil, when tested in the model, created an antidepressant response.

In one of the first studies to investigate mental toughness and stress and coping in high performing esports athletes, researchers have found similarities to traditional elite athletes.

Persistently engaging in negative thinking patterns may raise the risk of Alzheimer's disease, finds a new UCL-led study published in Alzheimer's & Dementia.

Chronic stress is associated with the pathogenesis of psychological disorders such as depression. A study is the first to identify the role of a neuronal receptor that straddles the intersection between social stress, inflammation, and anxiety in rodent models of stress. Findings suggest the possibility of developing better medications to treat the consequences of chronic stress by limiting inflammatory signaling not just generally, which may not be beneficial in the long run, but to specific brain circuits.

A new survey conducted during the COVID-19 pandemic found a more-than-threefold increase in the percentage of US adults who reported symptoms of psychological distress -- from 3.9 percent in 2018 to 13.6 percent in April 2020.

A wearable biosensor may help monitor stress experienced by healthcare professionals, according to a new study.

A review of 56 randomized clinical trials finds that psychological and behavioral therapies may be effective non-drug treatments for reducing disease-causing inflammation in the body.

A new study suggest that whether certain genes are expressed may play a role in susceptibility to post-traumatic stress disorder (PTSD).

Almost overnight, the rapid emergence of the COVID-19 pandemic in the United States and subsequent state and federal prevention measures dramatically altered daily behavior. A new study provides the first snapshot of the immediate impact of COVID-19 on Americans' stress levels, coping strategies, and adherence to public health guidelines.

The anaesthetic drug ketamine has been shown, in low doses, to have a rapid effect on difficult-to-treat depression. Researchers now report that they have identified a key target for the drug: specific serotonin receptors in the brain. Their findings give hope of new, effective antidepressants.